In cases of complicated urinary tract infections (UTI) treated with multiple-dose fosfomycin, clinical resolution occurred in 2 of 3 treatment episodes.
Fetroja® (cefiderocol) has been made available by Shionogi for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis caused by the following susceptible Gram-negative microorganisms: Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Enterobacter cloacae complex.
In pediatric patients, the duration of antibiotic treatment for uncomplicated UTI was not significantly associated with UTI recurrence.
A vegetarian diet is associated with a reduced risk for urinary tract infection.
The FDA has approved Fetroja for the treatment of complicated urinary tract infections.
Enhanced implementation on adoption of evidence-based antibiotic stewardship in nursing homes focused on the recognition and management of UTIs may improve the quality of antibiotic prescription in nursing homes.
With an improved specificity, an updated algorithm for the detection of UTIs in patients with relapsing MS addresses previous issues concerning the unnecessary prescription of antibiotics, whilst improving accuracy and maintaining safety.
A high dose and continuous infusion of cefoxitin has been associated with clinical success in treating febrile urinary tract infections in men caused by extended spectrum beta-lactamase–producing E coli.
The FDA’s Antimicrobial Drugs Advisory Committee voted in favor of approval of cefiderocol for the treatment of complicated UTIs including pyelonephritis.
Ceftazidime-avibactam was highly active against a large collection of gram-negative bacteria isolated from patients with complicated urinary tract infections.
No net benefit seen for screening, treatment of asymptomatic bacteriuria for nonpregnant adults
Antibiotic use within the previous 3 months and Middle Eastern ethnic background were risk factors for community-acquired urinary tract infection (UTI) caused by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in children treated at the Children’s Hospital of Michigan, according to study results published in Infectious Diseases. In this single center retrospective study, researchers identified 111 cases…
Healthcare professionals may inappropriately order urine cultures for patients with catheters, on the basis of subjective signs rather than evidence-based guidelines.
Represcription rate at 28 days only 4.1 percent from 2011 to 2015; slight increase seen for men over time
Initiation of therapy with SGLT-2 inhibitors for T2D mellitus is not associated with an increased risk for UTI events compared with initiation of other second-line antidiabetic medications.
The FDA has approved Recarbrio for the treatment of adult patients aged 18 years and older with complicated UTI.
Different infection types, especially UTI, are associated with subsequent acute ischemic stroke.
A significant percentage of patients with uncomplicated urinary tract infection (UTI) are treated with an empiric antibiotic agent to which the etiologic bacteria is resistant.
Fosfomycin for injection may show promise and noninferiority compared with standard treatment for complicated urinary tract infections.
For children with a normal urinary tract, probiotics were more effective than placebo at reducing the risk for UTI after the first episode of a febrile UTI.